In the present study, we explored the relationship between multimorbidity and frailty in a population of older individuals with cognitive disturbances attending a memory clinic. All subjects consecutively attending the Memory Clinic of the a first neurological evaluation were considered for the present analysis. Multimorbidity was defined as the simultaneous presence of two or more diseases in the same individual. A Frailty Index was computed by considering 44 age-related, multidimensional health deficits. Overall, 185 subjects were recruited in the study. A condition of multimorbidity was detected in 87.6% of the sample, whereas only the 44.6% of the study population was considered as frail. A poor agreement was observed between multimorbidity and frailty. The present findings confirm that counting diseases or health deficits may provide discordant information concerning the risk profile of older subjects.
Introduction
The adoption of models of care consenting to adequately capture the health status and the risk profile of the older person has become a pressing need in most medical disciplines, well beyond the geriatric boundaries. In particular, a broader and holistic viewpoint is required today for improving our clinical and research approach to cognitive disturbances. This may help at disentangling the intricate network of underlying pathophysiological mechanisms, sustaining the design and conduction of more calibrated interventions, and improving the allocation of healthcare resources [1] .
Interestingly, the clinical and biological complexity of the aging individual is increasingly estimated by mathematically counting his/her negative health attributes. The count of chronic diseases defines the concept of multimorbidity, intended as the co-occurrence of two or more diseases in the same individual [2] . The count of age-related health deficits (not restricted to traditional nosological entities, but also including signs, symptoms, and disabilities) is instead at the basis of the deficit accumulation model (or Frailty Index) proposed by Rockwood and Mitnitski [3] . The multimorbidity and deficit accumulation models share some commonalities and are frequently adopted interchangeably. After all, they were designed and respond to the same purpose of measuring the person's complexity. Nevertheless, the two follow distinct constructs and potentially provide different information in the clinical assessment of the older subject. In other words, they may differently inform and sustain clinical and public health interventions [2, 4] .
In the present study, we explored the relationship between multimorbidity and frailty in a population of older individuals with cognitive disturbances attending a memory clinic.
Materials and methods
All subjects consecutively attending the Memory Clinic of the Department of Human Neuroscience, "Sapienza" University of Rome, between January 2017 and April 2018 for a first neurological evaluation were considered for the present analysis. Participants underwent a detailed medical history collection and neurological and physical examination. Their global cognitive performance was assessed by means of the Mini Mental State Examination (MMSE) [5] . The Activities of Daily Living (ADL) [6] scale and the Instrumental ADL (IADL) [7] scale were adopted to evaluate their functional independence. Patients and/or their caregivers provided written informed consent for allowing the utilization of the collected data for research purposes.
The presence of the following 18 common medical conditions was recorded: osteoporosis; arthritis; hypertension; diabetes; dyslipidemia; ischemic heart disease; chronic heart failure; cancer; cardiac arrhythmia; chronic obstructive pulmonary disease; renal failure; gastric diseases; intestinal diseases; liver diseases; thyroid diseases; stroke; transient ischemic attack; peripheral artery diseases. The presence of these diseases was ascertained on the basis of: (a) self-reports concerning previous diagnoses and/or (b) available medical documents and/or (c) available medical prescriptions. Multimorbidity was defined as the simultaneous presence of two or more diseases in the same individual.
A Frailty Index was computed following a standard procedure [8] by considering 44 age-related, multidimensional health deficits (i.e., the above mentioned 18 chronic diseases plus symptoms, signs, and disabilities). Each item was coded as 0 (absence of the deficit) or 1 (presence of the deficit). The Frailty Index was then calculated as the ratio between the number of deficits exhibited by the participant and the number of considered deficits (i.e., 44). Thus, the score potentially ranged between 0 and 1. A cut-off of 0.25 was used to categorically define a frailty condition [9] .
The Cohen's kappa coefficient of agreement was tested between frailty and multimorbidity. Secondary analyses were conducted standardizing the cut-point of the two dichotomous variables of interest to the common values of 25% (that is raising the definition of multimorbidity to 4 or more diseases so to capture the same number of positive results as the FI) and 11% (that is lowering the definition of frailty to 5 or more deficits so to capture the same number of positive results as multimorbidity).
Results
Overall, 185 subjects (women 60.2%) attended our service for a first cognitive assessment in the considered time period. They had a mean age of 75.1 [standard deviation (SD) 8.3] years. They overall presented a mild impairment of cognitive performance in the presence of functional independence, as indicated by mean MMSE, ADL, and IADL scores of 23.3 (SD 6.3), 5.4 (SD 1.3), and 5.0 (SD 2.7), respectively. A condition of multimorbidity was detected in the 87.6% of the sample, with participating subjects exhibiting a mean of 3.8 (SD 2.1) chronic diseases (Fig. 1) . The Frailty Index ranged between 0.05 and 0.57 (median 0.22) ( Fig. 1) . Based on the adopted cut-point (i.e., ≥ 0.25), 44.6% of the study population was considered as frail. A poor agreement was observed between multimorbidity and frailty (k = 0.08; p = 0.06). In fact, only 93 subjects (50.3%) simultaneously met the criteria for both or none of the two conditions, whereas 86 (46.5%) individuals resulted as multimorbid but not as frail and 6 (3.2%) resulted as frail but not as multimorbid.
Although markedly improved, the agreement between the two constructs remained relatively modest, both when the defining cut-point for frailty was lowered to 11% (i.e., FI ≥ 0.11, that is equivalent to the multimorbidity standard; k = 0.45; p < 0.001) as well as when the defining cut-point for multimorbidity was increased to 4 or more diseases (i.e., 25%, that is equivalent to the FI standard; k = 0.44; p < 0.001).
Discussion
The present findings confirm that multimorbidity and frailty (here framed according to the deficit accumulation model) may provide different information concerning the clinical complexity of the older person and the stratification of his/her risk profile. In fact, despite being both (1) defined according to the arithmetical count of negative health attributes (i.e., diseases vs. deficits, respectively), and (2) similarly distributed in the study sample ( Fig. 1) , they exhibit a poor agreement in the identification of atrisk individuals. Consistently with the existing evidence, most frail individuals were also multimorbid whereas fewer multimorbid subjects presented a frailty condition [10] . This already observed discrepancy may be attributed to the existence of a temporal gap necessary for a condition of frailty to appear in multimorbid subjects. Such delta between the count of stand-alone diseases and the accumulation of deficits opens important research reflections. It may be considered as an indirect sign of resiliency at accumulating pathological changes [10] . It may also represent the result of largely unexplored interactions between diseases with a myriad of biological, psychological, social, and environmental determinants.
It might be argued that the difference between frailty and multimorbidity might be driven by the different rationale/ methodology applied in the definition of the critical thresholds of risk (i.e., 25% of deficits for frailty, and 11% of diseases for multimorbidity in our sample). However, the findings of the sensitivity analyses conducted standardizing the cut-point of the two variables to common values suggest that the two constructs should be considered as complementary rather than alternatives.
Of course, the lack of longitudinal data does not consent to appreciate which of the two models is better capable of mirroring the real health status of the individual and predicting his/her trajectories towards "hard" outcomes (e.g., mortality, hospitalization, institutionalization). Nevertheless, the observed ubiquitous presence of multimorbidity may somehow limit its discriminative role and overall clinical usefulness in our population. In other words, how can we draw clinical decisions (in terms of allocation of healthcare resources, frequency of follow-up, therapeutic choices) on the basis of a condition that is exhibited by nearly 90% of the subjects? Alternatively, a more rigid risk stratification can be obtained by adding to the model other subclinical and clinical deficits that, despite not meeting formal nosological frameworks, may strongly contribute to the health status and the clinical needs of the individual. In this regard, the Frailty Index allows the identification of a smaller number of subjects at increased risk for negative outcomes, potentially better supporting clinical decisions.
In conclusions, the present findings confirm how counting diseases or health deficits may provide discordant information concerning the risk profile of older subjects [4] . This should be carefully considered when planning and calibrating therapeutic and preventive interventions. The causal and temporal relationship between multimorbidity and deficit accumulation as well as their discriminating and predictive capacity should further be explored.
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